These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3383597)

  • 21. [Phlebitis. General aspects. Risk factors].
    de Dios Rubio R; Catalá Moya T; Sánchez Hita A
    Rev Enferm; 1987 Sep; 10(109):32-40. PubMed ID: 3685774
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of Intrafix® SafeSet infusion apparatus on phlebitis in a neurological intensive care unit: a case-control study.
    Liu F; Chen D; Liao Y; Diao L; Liu Y; Wu M; Xue X; You C; Kang Y
    J Int Med Res; 2012; 40(6):2321-6. PubMed ID: 23321189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of infusion-related phlebitis: review and nursing protocol.
    Perucca R; Micek J
    J Intraven Nurs; 1993; 16(5):282-6. PubMed ID: 8229430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infusion failure caused by phlebitis and extravasation.
    Wright A; Hecker J
    Clin Pharm; 1991 Aug; 10(8):630-4. PubMed ID: 1934920
    [No Abstract]   [Full Text] [Related]  

  • 25. Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells.
    Kuwahara T; Asanami S; Kubo S
    Nutrition; 1998 Jun; 14(6):496-501. PubMed ID: 9646289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innovative antibiotic therapy at home.
    Brown JM
    J Intraven Nurs; 1988; 11(6):397-401. PubMed ID: 3204447
    [No Abstract]   [Full Text] [Related]  

  • 27. Phlebitis rate and time kinetics of short peripheral intravenous catheters.
    Grüne F; Schrappe M; Basten J; Wenchel HM; Tual E; Stützer H;
    Infection; 2004 Feb; 32(1):30-2. PubMed ID: 15007740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Observation for clinical effect of phellodendron wet compress in treating the phlebitis caused by infusion.
    Wan Y
    Pak J Pharm Sci; 2018 May; 31(3(Special)):1099-1102. PubMed ID: 29735457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival of intravenous chemotherapy infusion sites.
    Hecker JF
    Br J Cancer; 1990 Oct; 62(4):660-2. PubMed ID: 2223586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The complications associated with the administration of 5-fluorouracil].
    Berdonces Fornieles M
    Rev Enferm; 1991 Dec; 14(160):58-60. PubMed ID: 1803433
    [No Abstract]   [Full Text] [Related]  

  • 31. [Risk factors for the development of phlebitis during intravenous infusion].
    van den Broek PJ; Mattie H
    Ned Tijdschr Geneeskd; 1998 Apr; 142(17):984. PubMed ID: 9623176
    [No Abstract]   [Full Text] [Related]  

  • 32. Potential for extending survival of peripheral intravenous infusions.
    Hecker JF
    BMJ; 1992 Mar; 304(6827):619-24. PubMed ID: 1472179
    [No Abstract]   [Full Text] [Related]  

  • 33. An analysis of phlebitis in a 240-bed hospital. Commemorative Reprint from NITA, Volume 4, No. 4, 1981.
    Faulkner LA; Miller D
    J Infus Nurs; 2007; 30(2):C1-4. PubMed ID: 17413488
    [No Abstract]   [Full Text] [Related]  

  • 34. Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis.
    Lanbeck P; Odenholt I; Riesbeck K
    J Antimicrob Chemother; 2004 Feb; 53(2):174-9. PubMed ID: 14729754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Notoginseny cream in the treatment of phlebitis.
    Gouping Z; Wan-Er T; Xue-Ling W; Min-Qian X; Kun F; Turale S; Fisher JW
    J Infus Nurs; 2003; 26(1):49-54. PubMed ID: 12544367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for peripheral intravenous catheter infection in hospitalized patients: a prospective study of 3165 patients.
    Lee WL; Chen HL; Tsai TY; Lai IC; Chang WC; Huang CH; Fang CT
    Am J Infect Control; 2009 Oct; 37(8):683-6. PubMed ID: 19559502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infusion phlebitis; selected factors.
    Ross SA
    Nurs Res; 1972; 21(4):313-8. PubMed ID: 4483283
    [No Abstract]   [Full Text] [Related]  

  • 38. Needleless IV access means fewer costs.
    Birk S
    Mater Manag Health Care; 2007 Jul; 16(7):46-8. PubMed ID: 17955936
    [No Abstract]   [Full Text] [Related]  

  • 39. Managing complications of i.v. therapy (continuing education credit).
    Millam DA
    Nursing; 1988 Mar; 18(3):34-43. PubMed ID: 3352974
    [No Abstract]   [Full Text] [Related]  

  • 40. Reducing infusion failure: a pharmacologic approach--a review.
    Wright A
    J Intraven Nurs; 1996; 19(2):89-97. PubMed ID: 8852169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.